Nevertheless, neither high CD4+ nor CD8+ lymphocytes were significantly associated with improved survival for patients with oral or laryngeal cancer, indicating that tumor location could be a more discriminating factor than TILs in terms of clinical outcome in HNSCC. This evidence concerns the gene CD8A and neoplasm.